Longeveron Inc. (LGVN)
NCM – Real vaqt narxi. Valyuta: USD
0.72
-0.01 (-1.85%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.71
-0.01 (-0.78%)
Bozordan keyin: Jun 26, 2026, 7:24 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
0.72
-0.01 (-1.85%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.71
-0.01 (-0.78%)
Bozordan keyin: Jun 26, 2026, 7:24 PM EDT
Longeveron Inc. klinik bosqichdagi biotexnologiya kompaniyasi bo'lib, Qo'shma Shtatlarda qarish bilan bog'liq va hayot uchun xavfli kasalliklar uchun hujayrali terapiyalarni ishlab chiqadi. Uning etakchi tadqiqot mahsuloti LOMECEL-B, yosh va sog'lom kattalar donorlarining suyak iligidan olingan allogenik mezenximal stam hujayra formulasi bo'lib, gipoplastik chap yurak sindromini davolash uchun 3-faza klinik sinovidan o'tmoqda; Altsgeymer kasalligini davolash uchun 2a fazali klinik sinovni yakunladi, shuningdek, qarish zaifligini davolash uchun 2b fazali klinik sinovdan o'tmoqda. Kompaniya 2014-yilda tashkil etilgan va Mayami, Florida shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Joshua Michael Hare FACC, M.D. | Co-Founder, Chief Science Officer & Executive Chairman |
| Dr. Nataliya Agafonova M.D. | Chief Medical Officer |
| Mr. Brian G Rash Ph.D. | Vice President of Research & Discovery |
| Mr. Devin Blass | CTO and Senior VP of Chemistry, Manufacturing & Controls |
| Mr. Paul T. Lehr J.D. | General Counsel & Secretary |
| Mr. Stephen H. Willard Esq. | Chief Executive Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-05 | 8-K | ea0293758-8k_longeveron.htm |
| 2026-05-20 | DEFA14A | ea0289252-05.htm |
| 2026-05-20 | DEF 14A | ea0289252-04.htm |
| 2026-05-13 | 8-K | ea0290436-8k_longeveron.htm |
| 2026-05-13 | 10-Q | lgvn-20260331.htm |
| 2026-05-08 | 8-K | ea0289853-8k_longeveron.htm |
| 2026-05-05 | PRE 14A | ea0289252-01.htm |
| 2026-04-15 | CORRESP | filename1.htm |
| 2026-04-10 | S-1 | ea0285827-s1_longeveron.htm |
| 2026-04-10 | 8-K | ea0285933-8k_longeveron.htm |
| Ms. Lisa McClain-Moss | Vice President of Manufacturing |
| Ms. Lisa A. Locklear M.B.A. | CFO, Executive VP & Treasurer |